BRPI0700832A - composição anestésica nanoparticulada para uso tópico - Google Patents

composição anestésica nanoparticulada para uso tópico

Info

Publication number
BRPI0700832A
BRPI0700832A BRPI0700832-5A BRPI0700832A BRPI0700832A BR PI0700832 A BRPI0700832 A BR PI0700832A BR PI0700832 A BRPI0700832 A BR PI0700832A BR PI0700832 A BRPI0700832 A BR PI0700832A
Authority
BR
Brazil
Prior art keywords
nanoparticulate
topical use
anesthetic composition
anesthetic
composition
Prior art date
Application number
BRPI0700832-5A
Other languages
English (en)
Inventor
Dante Alario Jr
Guterres Silvia Staniscuaski
Pohlmann Adriana Raffin
Lali Ronsoni Zancan
Original Assignee
Biolab Sanus Farmaceutica Ltda
Univ Fed Do Rio Grande Do Sul
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39765309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0700832(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biolab Sanus Farmaceutica Ltda, Univ Fed Do Rio Grande Do Sul filed Critical Biolab Sanus Farmaceutica Ltda
Priority to BRPI0700832A priority Critical patent/BRPI0700832B8/pt
Priority to EP08714517.3A priority patent/EP2134334B1/en
Priority to CL200800728A priority patent/CL2008000728A1/es
Priority to PT87145173T priority patent/PT2134334T/pt
Priority to PL08714517T priority patent/PL2134334T3/pl
Priority to HUE08714517A priority patent/HUE051155T2/hu
Priority to MX2009009853A priority patent/MX2009009853A/es
Priority to US12/531,404 priority patent/US8568788B2/en
Priority to JP2009553872A priority patent/JP5496684B2/ja
Priority to PCT/BR2008/000070 priority patent/WO2008113144A1/en
Priority to ES08714517T priority patent/ES2804466T3/es
Priority to ARP080101035A priority patent/AR065723A1/es
Priority to PE2013000512A priority patent/PE20131337A1/es
Priority to PE2008000474A priority patent/PE20081883A1/es
Publication of BRPI0700832A publication Critical patent/BRPI0700832A/pt
Priority to EC2009009691A priority patent/ECSP099691A/es
Priority to CO09114245A priority patent/CO6220944A2/es
Publication of BRPI0700832B1 publication Critical patent/BRPI0700832B1/pt
Publication of BRPI0700832B8 publication Critical patent/BRPI0700832B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSIçãO ANESTéSICA NANOPARTICULADA PARA USO TóPICO. A presente invenção se refere a uma composição anestésica nanoparticulada para uso tópico em que pelo menos um agente anestésico local está encapsulado em nanopartículas poliméricas. A presente invenção também se refere ao uso de tais nanopartículas políméricas compreendendo pelo menos um agente anestésico local, na preparação de uma composição anestésica para aplicação tópica sobre a pele ou mucosas.
BRPI0700832A 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína BRPI0700832B8 (pt)

Priority Applications (16)

Application Number Priority Date Filing Date Title
BRPI0700832A BRPI0700832B8 (pt) 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína
CL200800728A CL2008000728A1 (es) 2007-03-16 2008-03-12 Composicion anestesica para la administracion topica que comprende un agente anestesico local en nanoparticulas polimericas y por lo menos un agente que aumenta la viscosidad.
JP2009553872A JP5496684B2 (ja) 2007-03-16 2008-03-12 局所使用のためのナノ粒子状麻酔薬組成物
ES08714517T ES2804466T3 (es) 2007-03-16 2008-03-12 Composición anestésica de uso tópico en forma de nanopartículas
PT87145173T PT2134334T (pt) 2007-03-16 2008-03-12 Composição anestésica nanoparticulada para utilização tópica
PL08714517T PL2134334T3 (pl) 2007-03-16 2008-03-12 Kompozycja znieczulająca w postaci nanocząstek do miejscowego stosowania
HUE08714517A HUE051155T2 (hu) 2007-03-16 2008-03-12 Nanorészecske formájú fájdalomcsillapító készítmény topikális alkalmazásra
MX2009009853A MX2009009853A (es) 2007-03-16 2008-03-12 Composicion anestesica nanoparticulada para la administracion topica.
US12/531,404 US8568788B2 (en) 2007-03-16 2008-03-12 Nanoparticulated anesthetic composition for topic use
EP08714517.3A EP2134334B1 (en) 2007-03-16 2008-03-12 Nanoparticulated anesthetic composition for topic use
PCT/BR2008/000070 WO2008113144A1 (en) 2007-03-16 2008-03-12 Nanoparticulated anesthetic composition for topic use
ARP080101035A AR065723A1 (es) 2007-03-16 2008-03-13 Composicion anestesica nanoparticulada para la administracion topica
PE2008000474A PE20081883A1 (es) 2007-03-16 2008-03-13 Composicion anestesica nanoparticulada para la administracion topica
PE2013000512A PE20131337A1 (es) 2007-03-16 2008-03-13 Composicion anestesica nanoparticulada para la administracion topica
EC2009009691A ECSP099691A (es) 2007-03-16 2009-10-14 Composición anestésica nanoparticulada para la administración tópica
CO09114245A CO6220944A2 (es) 2007-03-16 2009-10-14 Composicion anestesica nanoparticulada para la administracion topica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0700832A BRPI0700832B8 (pt) 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína

Publications (3)

Publication Number Publication Date
BRPI0700832A true BRPI0700832A (pt) 2008-11-04
BRPI0700832B1 BRPI0700832B1 (pt) 2017-12-26
BRPI0700832B8 BRPI0700832B8 (pt) 2021-05-25

Family

ID=39765309

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0700832A BRPI0700832B8 (pt) 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína

Country Status (15)

Country Link
US (1) US8568788B2 (pt)
EP (1) EP2134334B1 (pt)
JP (1) JP5496684B2 (pt)
AR (1) AR065723A1 (pt)
BR (1) BRPI0700832B8 (pt)
CL (1) CL2008000728A1 (pt)
CO (1) CO6220944A2 (pt)
EC (1) ECSP099691A (pt)
ES (1) ES2804466T3 (pt)
HU (1) HUE051155T2 (pt)
MX (1) MX2009009853A (pt)
PE (2) PE20131337A1 (pt)
PL (1) PL2134334T3 (pt)
PT (1) PT2134334T (pt)
WO (1) WO2008113144A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2497679C2 (ru) 2008-10-02 2013-11-10 Милан Инк. Способ получения многослойного клеящегося ламинированного материала
BR102012022036B1 (pt) * 2012-08-31 2019-10-01 Biolab Sanus Farmacêutica Ltda. Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso
BR102014028009B1 (pt) 2014-11-10 2023-04-18 Universidade Federal De Pelotas Composições filmogênicas para bioadesivos anestésicos tópicos (bats) para liberação controlada de princípios ativos e bioadesivos anestésicos tópicos
US11452700B2 (en) 2017-08-04 2022-09-27 Eric Haas Method of delivering an anesthetic agent and glucocorticoid micro and nano bioerodible particles
CN113244167B (zh) * 2021-05-20 2022-11-29 河北科技大学 一种盐酸利多卡因凝胶及其制备方法
RU208882U1 (ru) * 2021-08-25 2022-01-19 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курская государственная сельскохозяйственная академия имени И.И. Иванова" Раневая атравматическая повязка для животных
CN119950421B (zh) * 2025-04-11 2025-07-08 北华大学 一种含有三甲卡因的麻醉制剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7713618L (sv) * 1977-12-01 1979-06-02 Astra Laekemedel Ab Lokalanestetisk blandning
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
DE4120760A1 (de) * 1991-06-24 1993-03-04 3 M Medica Gmbh Traegersysteme fuer arzneimittel
JPH09255565A (ja) * 1996-03-26 1997-09-30 Daikyo Yakuhin Kogyo Kk 皮膚局所麻酔用ヒドロゲルパッチ
BR9815499A (pt) 1997-07-02 2001-01-02 Euro Celtique Sa Anestesia prolongada nas juntas e nos espacos corporais.
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
KR100463167B1 (ko) * 2001-04-13 2004-12-23 주식회사 태평양 고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
US20070154527A1 (en) * 2001-10-12 2007-07-05 Monosoirx, Llc Topical film compositions for delivery of actives
WO2006002365A2 (en) 2004-06-24 2006-01-05 Angiotech International Ag Microparticles with high loadings of a bioactive agent
JP2008517927A (ja) * 2004-10-21 2008-05-29 ユニバーシティー オブ アイオワ リサーチ ファンデーション ｉｎｓｉｔｕ制御放出薬剤送達システム
WO2006091719A2 (en) * 2005-02-23 2006-08-31 Sontra Medical Corporation Compositions and methods enhancing transdermal delivery of drugs and biologics

Also Published As

Publication number Publication date
EP2134334B1 (en) 2020-05-13
HUE051155T2 (hu) 2021-03-01
US20100086614A1 (en) 2010-04-08
US8568788B2 (en) 2013-10-29
PT2134334T (pt) 2020-08-20
PL2134334T3 (pl) 2021-03-08
ECSP099691A (es) 2010-02-26
EP2134334A4 (en) 2013-04-24
MX2009009853A (es) 2010-02-18
PE20081883A1 (es) 2008-12-27
PE20131337A1 (es) 2013-11-18
JP5496684B2 (ja) 2014-05-21
WO2008113144A1 (en) 2008-09-25
BRPI0700832B8 (pt) 2021-05-25
CL2008000728A1 (es) 2008-09-26
AR065723A1 (es) 2009-06-24
CO6220944A2 (es) 2010-11-19
BRPI0700832B1 (pt) 2017-12-26
EP2134334A1 (en) 2009-12-23
JP2010521498A (ja) 2010-06-24
ES2804466T3 (es) 2021-02-08

Similar Documents

Publication Publication Date Title
HN2009000784A (es) Dihidropirazolonas sustituidas
BRPI0921002A8 (pt) Composições para tratamento bucal compreendendo sílica fundida e seu uso
CL2008000893A1 (es) Composición para el cuidado bucal que comprende una cantidad efectiva de un aminoácido básico y un agente antibacteriano; uso en el tratamiento antibacteriano de la cavidad bucal.
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
BRPI1103213B8 (pt) Composição de enxaguatório bucal antimicrobiano com teor alcoólico reduzido à base de óleo essencial bioativo
BRPI0921249A8 (pt) uso de matriz extracelular na preparação de uma composição,uso de matriz extracelular e agente quimioterápico na preparação de uma composição, e composições para o tratamento do cãncer
UY31765A (es) Dihidropirazolonas sustituidas y su uso
ECSP099691A (es) Composición anestésica nanoparticulada para la administración tópica
BR112012009135A2 (pt) composição polímera termoplástica
AR077199A1 (es) Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia
BR112016013195A2 (pt) Composições para a higiene bucal compreendendo carbonato de cálcio e uma argila
BR112013026965A2 (pt) método para inibir micro-organismos prejudiciais e composição formadora de barreira para os mesmos
BR112014010457B8 (pt) processo para a fabricação de uma composição cosmética
BR112016013194A2 (pt) Composições de higiene oral compreendendo carbonato de cálcio e sílica
CR20130684A (es) Composición limpiadora que comprende un agente gelificante y un tensioactivo empumante
CL2012003168A1 (es) Composicion farmaceutica que comprende una solucion acuosa de minociclina y un cation divalente o trivalente en una proporcion mayor de 2:1 con respecto a la minociclina; metodo de preparacion; kit y uso en el tratamiento de infecciones bacterianas.
CL2011003327A1 (es) Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales.
BR112013004455A2 (pt) composições para fornecimento gástrico de agentes ativos
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
MX347670B (es) 1h-pirazol-5-olato sodico sustituido.
BR112014002060A2 (pt) composições para uso na seção úmida da fabricação de papel
BR112012032540A2 (pt) formulação de solução de lactona macrocíclica, e, uso da formulação veterinária
FR2966698B1 (fr) Composition dermo-cosmetique anti-microbienne pour animaux
BR112013030282A2 (pt) composições compreendendo agente antibacteriano e tazobactama
CL2008000026A1 (es) Compuestos derivados de quinolona; composicion farmaceutica que contiene dichos compuestos; metodo de preparacion de la composicion farmaceutica; y su uso como agente antibacteriano.

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B65X Notification of requirement for priority examination of patent application
B65Y Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117)
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/12/2017, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61K 9/51 (2006.01), A61P 23/02 (2006.01)

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/03/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF